Nordea raises Demant target: Demant stock sits 0.18 percent below its high
Published on 10/06/2026 at 12:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Demant (ISIN DK0060738599) was trading at EUR 43.51 at Lang & Schwarz on October 6, 2026 at 12:02 p.m. CEST, up 2.52 percent versus the prior close of EUR 42.44. Nordea raised its price target for Demant on October 5, 2026, while the DKK 325.00 primary-exchange quote stood 0.18 percent below its DKK 325.60 52-week high. MedWatch linked the target increase to stronger US demand for Oticon Zeal.
Guidance moves higher
Demant reported 15.00 percent revenue growth in the first half of 2026, with EBIT before special items of DKK 2.13 billion and an EBIT margin of 16.50 percent. The figures give the company a stronger base for the second half, but the market backdrop remains an important variable.
According to Yahoo Finance on August 12, 2026, management upgraded full-year 2026 organic revenue growth guidance to 6.00-7.00 percent and EBIT before special items to DKK 4.40-4.80 billion. Operating cash flow reached DKK 1.60 billion in the first half, up 6.00 percent from the first half of 2025.
Zeal drives the operating story
Oticon Zeal delivered 10.00 percent hearing-aid growth in the second quarter of 2026 after its rollout across channels and geographies. Management also said the upcoming Oticon Reveal platform is intended to support momentum and enable a net price increase versus Oticon Intent.
The growth mix is the key investor issue. Acquisitions contributed 10.00 percentage points to reported first-half growth, while organic growth was 7.00 percent, showing that Demant's expansion combines portfolio momentum with the KIND acquisition.
Stock near its yearly high
On Nasdaq Copenhagen, Demant was last at DKK 325.00 on October 6, 2026 at 12:05 p.m. CEST, against a DKK 319.20 prior close and a DKK 175.00 52-week low. The DKK 68.5 billion market capitalization places the 0.18 percent gap to the yearly high in clear view.
Markets Insider reported on October 2, 2026 that Barclays maintained a Hold rating with a DKK 270.00 price target. Its cited consensus target was DKK 306.26, leaving a clear split between cautious valuation views and the company's upgraded operating outlook.
Price and investor perspective
Demant's Lang & Schwarz quote was EUR 43.51 on October 6, 2026 at 12:02 p.m. CEST, plus 2.52 percent versus the prior close of EUR 42.44. The further course of trading is shown by the continuously updated real-time quote of Demant stock.
Demant stock facts
- Company: Demant A/S
- ISIN: DK0060738599
- Ticker: DEMANT.CO
- Primary exchange: Nasdaq Copenhagen
- Price Lang & Schwarz as of October 6, 2026 at 12:02 p.m. CEST: EUR 43.51
- Change versus prior close: plus 2.52 percent
- Prior close Lang & Schwarz October 5, 2026: EUR 42.44
- Market capitalization: DKK 68.5 billion as of October 6, 2026
- 52-week range: DKK 175.00-325.60 as of October 6, 2026
- Sector / Industry: Healthcare / Medical Devices
